R&D Lab Manager
279 East Grand Avenue
South San Francisco, CA 94080
About the Role
Freenome is seeking an experienced lab manager to oversee its Research & Development (R&D) laboratory. Comprising over 40 research associates and scientists, the R&D Lab is responsible for building, optimizing, and developing the molecular assays within Freenome’s Multiomics Discovery Platform and commercial diagnostic tests. As the R&D Lab Manager, you will be responsible for maintaining and scaling the laboratory as it continues to expand in personnel, footprint, and scope. You will oversee the processes that keep the lab running smoothly and be the point person for cross-functional interactions with Facilities, Supply Chain, and the Clinical Laboratory.
How you’ll contribute:
- Provide lab leadership to our Research, Development, and Translational Science teams (which together form the R&D Lab)
- Implement and maintain processes for cold storage organization, lab safety, equipment scheduling, lab notebook auditing, and general lab upkeep
- Partner with Supply Chain to ensure adequate supplies of consumables and reagents
- Onboard new employees into the lab
- Forecast and track lab budget
- Plan and execute the physical expansion of the R&D Lab in collaboration with Facilities
- Assume responsibility for Freenome’s R&D sample biobank
- Develop new policies and processes to improve lab efficiencies
What you’ll bring:
- 4+ years of experience independently managing a lab (without day-to-day oversight) in industry or academia
- Exceptional communication and collaboration skills
- Proven track record of championing processes that improve efficiency in the lab
How to Apply
About Our Organization
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent cancer.
We have pioneered the most comprehensive multiomics platform for early cancer detection through a routine blood draw. By combining deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science.
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.
Freenome is building technology to advance the understanding of cancer through multiple analytes derived from blood. These signals include cell-free DNA, methylation of cell-free DNA, cell-free RNA, circulating proteins, and immune profiling derived from thousands of prospective samples. By developing novel statistical learning methods and applying them to integrate various -omics datasets, Freenome is a leader in modeling specific biological mechanisms to capture disease-dependent signatures, including gene expression, immune response, tumor burden, the tissue of origin, and 3D chromatin structure.
By building comprehensive discovery datasets and modeling critical biological systems, Freenome is learning what biological changes are present within the blood between a variety of different disease states, including cancer, autoimmune disorders, infections, drug response, and aging. The synthesis of Freenome’s datasets, cross-functional technical expertise, and audacious mission to discover biological truth, we seek to improve the lives of millions through early detection and early treatment of disease.
Freenomers are technical, creative, visionary, grounded, empathetic, and passionate. We build teams around divergent expertise, allowing us to solve problems and ascertain opportunities in unique ways. Freenomers are some of the most talented experts in their fields, joining together to advance healthcare, one breakthrough at a time.
We value empathy, integrity, and trust in one another, and we respect the diverse perspectives of our colleagues and those we serve. We assume positive intent and give each other the benefit of the doubt with the firm belief that we are a team working toward the same objectives. We believe in empowering and supporting each other in a collaborative and dynamic environment.
What does a successful person look like at Freenome?
Those who thrive at Freenome prioritize, manage, and execute their own goals with ownership and alignment with those of the company. They embrace our values of empathy, integrity, striving for greatness, servant leadership, trust, and holding themselves and their team accountable to these values. They crave collaboration with brilliant minds from disparate fields of study and believe that hiring and mentorship are fundamental to our success. Above all, they welcome and provide constructive feedback and criticism, trusting in others’ good intentions, and being secure in knowing that embracing mistakes is the best way to learn and grow. For those who pursue challenges, understudied problems, and want the opportunity to see their work impact the lives of millions of people affected by cancer every year, there’s no better place to be than Freenome.
Freenome is proud to be an equal opportunity employer and we value diversity. Freenome does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status, or any other basis covered by appropriate law.